This is a 3 year product paying in Euro issued by UBS AG. It is Express Certificate Plus linked to the performance of Astrazeneca PLC, Merck & Co Inc and Novartis Inc from 02/18/2019 to the last observation date 02/18/2022 and will be monitored at quarterly periods. The product will mature early if on any quarterly date, from period 1, the worst performing underlying is at or above 100%, 100%, 100%, 100%, ... ,90%, 90% and 90% of its initial level (on the relevant date). In this case the product will repay the initial investment plus a coupon of 2.25% (on the relevant date when the autocall is triggered). Otherwise the product will pay a coupon of 2.25% if the underlying is at or above the 75% of its initial level. If the product runs to maturity, it will repay the initial investment plus a coupon of 2.25% so long as the worst performing underlying is at or above 75% . If the European protection barrier of 64% has not been breached, the nominal value will be paid, otherwise the product will repay the initial investment less any negative worst performing underlying measured over the term of the product
Lyfecycle: Early Matured | Fair Value: Sign-in
UBS Phoenix Memory AZN MRK NOVN 2.25 - 25.02.2022
The product has matured at 2/18/2020. Investing in this product at issue price would have resulted in a total return of 1.45%
Free Sign-in to view contract terms.
More options and tools
- Need more detailed information including backtesting, what-if analysis, greeks or the Fairmat independent quantitative report? Request an on-demand analytics.
- Want to assess a custom product similar to this one? Clone this product and modify it.
- Want to Find, Compare and Rank Similar Products? Sign-in to access the Products Ranking And Comparison Tools.
Disclaimer: this product sheet has been created by Fairmat Srl and its partners using public available information, hence it represents our interpretation of the product. The information displayed in this page does not represent any recommendation to buy or sell the displayed product.